• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

需要重症监护治疗急性呼吸窘迫综合征的新冠肺炎患者与非新冠肺炎患者的生存分析:一项观察性回顾性研究。

Survival analysis of COVID-19 versus non-COVID-19 patients requiring intensive care for acute respiratory distress syndrome: An observational retrospective study.

作者信息

Navas Boada Paulo, Chamorro Kevin, Ballaz Santiago

机构信息

School of Biological Sciences and Engineering Universidad Yachay Tech.

School of Mathematics and Computational Sciences Universidad Yachay Tech.

出版信息

Can J Respir Ther. 2024 Aug 21;60:112-121. doi: 10.29390/001c.122402. eCollection 2024.

DOI:10.29390/001c.122402
PMID:39268526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11392457/
Abstract

BACKGROUND/AIM: This study analyzed clinical factors impacting the survival of COVID-19 patients with acute respiratory distress síndrome, or ARDS (CARDS) to ICU compared to non-COVID-19 ARDS patients.

METHODS

Clinical variables from 1,008 CARDS cases and 332 ARDS cases were computed using learning algorithms. The multivariable Cox proportional hazards regression models with the enter method evaluated risk factors and ICU mortality relationships. The survival analysis was completed with Kaplan-Meier and the log-rank tests.

RESULTS

A Random Forest model revealed that mechanical ventilation-related factors, oxygenation, blood pH, superinfection, shock, and ICU length of stay have the greatest effects on ICU survival. According to a multivariate Cox model, reintubation and a high-flow nasal cannula were essential for survival in CARDS patients during the ICU stay. The length of stay in the ICU diminishes in patients older than 45 years, regardless of the source of ARDS.

CONCLUSION

This study gives recommendations for the respiratory care of ARDS in COVID-19 patients.

摘要

背景/目的:本研究分析了与非新冠肺炎急性呼吸窘迫综合征(ARDS)患者相比,影响新冠肺炎急性呼吸窘迫综合征(CARDS)患者入住重症监护病房(ICU)后生存的临床因素。

方法

使用学习算法计算1008例CARDS病例和332例ARDS病例的临床变量。采用逐步回归法的多变量Cox比例风险回归模型评估风险因素与ICU死亡率的关系。生存分析采用Kaplan-Meier法和对数秩检验完成。

结果

随机森林模型显示,机械通气相关因素、氧合、血液pH值、二重感染、休克和ICU住院时间对ICU生存影响最大。根据多变量Cox模型,再次插管和高流量鼻导管对CARDS患者在ICU住院期间的生存至关重要。无论ARDS的病因如何,45岁以上患者的ICU住院时间都会缩短。

结论

本研究为新冠肺炎患者ARDS的呼吸护理提供了建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/11392457/94eb53e68caf/cjrt_2024_60_122402_241149.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/11392457/0ccc4769881c/cjrt_2024_60_122402_241146.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/11392457/8c144fb80596/cjrt_2024_60_122402_241148.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/11392457/94eb53e68caf/cjrt_2024_60_122402_241149.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/11392457/0ccc4769881c/cjrt_2024_60_122402_241146.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/11392457/8c144fb80596/cjrt_2024_60_122402_241148.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0256/11392457/94eb53e68caf/cjrt_2024_60_122402_241149.jpg

相似文献

1
Survival analysis of COVID-19 versus non-COVID-19 patients requiring intensive care for acute respiratory distress syndrome: An observational retrospective study.需要重症监护治疗急性呼吸窘迫综合征的新冠肺炎患者与非新冠肺炎患者的生存分析:一项观察性回顾性研究。
Can J Respir Ther. 2024 Aug 21;60:112-121. doi: 10.29390/001c.122402. eCollection 2024.
2
[Value of modified ROX index in predicting the outcome of patients with acute respiratory distress syndrome due to SARS-CoV-2 infection treated with high-flow nasal cannula oxygen therapy].[改良ROX指数对预测新型冠状病毒2型感染所致急性呼吸窘迫综合征患者接受高流量鼻导管吸氧治疗预后的价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Jun;36(6):585-590. doi: 10.3760/cma.j.cn121430-20240228-00171.
3
Early Improvement of Acute Respiratory Distress Syndrome in Patients With COVID-19 in the Intensive Care Unit: Retrospective Analysis.COVID-19 患者 ICU 中急性呼吸窘迫综合征的早期改善:回顾性分析。
JMIR Public Health Surveill. 2021 Mar 9;7(3):e24843. doi: 10.2196/24843.
4
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study.皮质类固醇治疗与机械通气的新型冠状病毒肺炎相关急性呼吸窘迫综合征(ARDS)患者的死亡率:一项多中心队列研究
Ann Intensive Care. 2021 Nov 26;11(1):159. doi: 10.1186/s13613-021-00951-0.
5
[Diagnostic value of mechanical power in patients with moderate to severe acute respiratory distress syndrome: an analysis using the data from MIMIC-III].[机械功率在中重度急性呼吸窘迫综合征患者中的诊断价值:一项基于MIMIC-III数据的分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Jan;34(1):35-40. doi: 10.3760/cma.j.cn121430-20210630-00978.
6
[Dynamic measurement of volume of atelectasis area in the evaluation of the prognosis of patients with moderate-to-severe acute respiratory distress syndrome].[动态测量肺不张面积在中重度急性呼吸窘迫综合征患者预后评估中的应用]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Sep;32(9):1056-1060. doi: 10.3760/cma.j.cn121430-20191219-00056.
7
A Retrospective Comparison of Clinical and Laboratory Aspects of Patients With COVID-19-Related Acute Respiratory Distress Syndrome (ARDS) and Non-COVID-19-Related ARDS.新型冠状病毒肺炎相关急性呼吸窘迫综合征(ARDS)与非新型冠状病毒肺炎相关ARDS患者的临床及实验室指标回顾性比较
Cureus. 2024 Jul 4;16(7):e63794. doi: 10.7759/cureus.63794. eCollection 2024 Jul.
8
COVID-19 Induced Acute Respiratory Distress Syndrome-A Multicenter Observational Study.新型冠状病毒肺炎所致急性呼吸窘迫综合征——一项多中心观察性研究
Front Med (Lausanne). 2020 Dec 18;7:599533. doi: 10.3389/fmed.2020.599533. eCollection 2020.
9
Association between pre-ICU aspirin administration and ARDS mortality in the MIMIC-IV database: A cohort study.在 MIMIC-IV 数据库中,ICU 前阿司匹林给药与 ARDS 死亡率之间的关联:一项队列研究。
Pulm Pharmacol Ther. 2024 Jun;85:102288. doi: 10.1016/j.pupt.2024.102288. Epub 2024 Mar 8.
10
Early prone positioning in acute respiratory distress syndrome related to COVID-19: a propensity score analysis from the multicentric cohort COVID-ICU network-the ProneCOVID study.COVID-19 相关急性呼吸窘迫综合征患者早期俯卧位治疗:COVID-ICU 网络多中心队列研究(ProneCOVID 研究)的倾向评分分析。
Crit Care. 2022 Mar 24;26(1):71. doi: 10.1186/s13054-022-03949-7.

本文引用的文献

1
Acute respiratory distress syndrome in patients with COVID-19 vs. Non-COVID-19: clinical characteristics and outcomes in a tertiary care setting in Mexico City.COVID-19 与非 COVID-19 患者的急性呼吸窘迫综合征:墨西哥城一家三级护理中心的临床特征和结局。
BMC Pulm Med. 2023 Nov 6;23(1):430. doi: 10.1186/s12890-023-02744-6.
2
Risk Factors and Outcomes Associated With Re-Intubation Secondary to Respiratory Failure in Patients With COVID-19 ARDS.新型冠状病毒肺炎急性呼吸窘迫综合征患者继发于呼吸衰竭的再次插管相关危险因素及预后
Respir Care. 2023 Dec 28;69(1):50-60. doi: 10.4187/respcare.10881.
3
Same but Different? Comparing the Epidemiology, Treatments and Outcomes of COVID-19 and Non-COVID-19 ARDS Cases in Germany Using a Sample of Claims Data from 2021 and 2019.
相同但又不同?利用 2021 年和 2019 年索赔数据样本比较德国 COVID-19 和非 COVID-19 ARDS 病例的流行病学、治疗方法和结局。
Viruses. 2023 Jun 5;15(6):1324. doi: 10.3390/v15061324.
4
An observational study on factors associated with ICU mortality in Covid-19 patients and critical review of the literature.一项关于与新冠病毒患者 ICU 死亡率相关因素的观察性研究及文献综述。
Sci Rep. 2023 May 13;13(1):7804. doi: 10.1038/s41598-023-34613-x.
5
Ventilatory ratio and mechanical power in prolonged mechanically ventilated COVID-19 patients respiratory failures of other etiologies.机械通气时间延长的 COVID-19 患者与其他病因所致呼吸衰竭患者的通气比值和机械功率。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231155744. doi: 10.1177/17534666231155744.
6
Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP.感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)不同变异株的社区获得性肺炎(CAP)住院患者及非新型冠状病毒肺炎(COVID-19)CAP患者的特征、结局及影响死亡率的因素
J Clin Med. 2023 Feb 9;12(4):1388. doi: 10.3390/jcm12041388.
7
Adherence to protective mechanical ventilation in COVID-19 versus non-COVID-19-associated acute respiratory distress syndrome: Comparison between two prospective cohorts.COVID-19 与非 COVID-19 相关的急性呼吸窘迫综合征患者机械通气保护策略的依从性:两个前瞻性队列的比较。
Med Intensiva (Engl Ed). 2023 Aug;47(8):445-453. doi: 10.1016/j.medine.2023.01.004. Epub 2023 Jan 30.
8
Outcomes Among Mechanically Ventilated Patients With Severe Pneumonia and Acute Hypoxemic Respiratory Failure From SARS-CoV-2 and Other Etiologies.严重肺炎和急性低氧性呼吸衰竭机械通气患者的结局:来自 SARS-CoV-2 和其他病因。
JAMA Netw Open. 2023 Jan 3;6(1):e2250401. doi: 10.1001/jamanetworkopen.2022.50401.
9
Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis.新冠肺炎患者在疫情四波期间插管时机的影响:一项匹配分析。
Eur Respir J. 2023 Mar 2;61(3). doi: 10.1183/13993003.01426-2022. Print 2023 Mar.
10
Clinical outcomes and lung mechanics characteristics between COVID-19 and non-COVID-19-associated acute respiratory distress syndrome: a propensity score analysis of two major randomized trials.COVID-19 与非 COVID-19 相关的急性呼吸窘迫综合征的临床结局和肺力学特征:两项主要随机试验的倾向评分分析。
Rev Bras Ter Intensiva. 2022 Nov 4;34(3):335-341. doi: 10.5935/0103-507X.20220040-pt. eCollection 2022.